Nisha Shaha20 May, 2022Business
The global Biomarkers market accounted for US$ 47.02 billion in 2020 and is estimated to be US$ 161.78 billion by 2030 and is anticipated to register a CAGR of 13.1%. A biomarker is a characteristic that may be tested and evaluated as a reliable indicator of a physiological or pathological process, as well as the pharmacological response to a therapeutic intervention. Biomarkers can be used to track the progression of diseases, as well as their regression and prognosis after treatment.
Zoran Kukic
Rokah Karate
K88
Win678
Ag官网 App下载
F168
8xx
Proglobalpublishing
Koenig Curran
Wall Hull